» Articles » PMID: 23058983

How Can We Use Depression Severity to Guide Treatment Selection when Measures of Depression Categorize Patients Differently?

Overview
Specialty Psychiatry
Date 2012 Oct 13
PMID 23058983
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Treatment guidelines for depression suggest that severity should be taken into account when initiating treatment. If clinicians are to consider illness severity in selecting among treatment options for depression, then it is important to have reliable, valid, and clinically useful methods of distinguishing between levels of depression severity. In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we compared 3 self-report scales that assess the DSM-IV criteria for major depressive disorder on the basis of how these scales distribute patients into severity categories.

Method: From June 2010 to November 2011, 245 depressed outpatients completed the Clinically Useful Depression Outcome Scale (CUDOS), Quick Inventory of Depressive Symptomatology (QIDS), and Patient Health Questionnaire (PHQ-9). The study was conducted at Rhode Island Hospital, Providence, Rhode Island. The patients were subdivided into severity categories according to the cutoff scores recommended by each scales' developers. The patients were also rated on the 17-item Hamilton Depression Rating Scale (HDRS-17).

Results: The correlations between the HDRS-17 and the 3 self-report scales were nearly identical. Yet the scales significantly differed in their distribution of patients into severity categories. On the CUDOS and HDRS-17, moderate depression was the most frequent severity category, whereas on the PHQ-9 and QIDS, the majority of the patients were classified as severe. Significantly fewer patients were classified as severely depressed on the CUDOS compared to the PHQ-9 (McNemar = 153.8; P < .001) and QIDS (McNemar = 114.0; P < .001).

Conclusions: If clinicians are to follow treatment guidelines' recommendations to base initial treatment selection on the severity of depression, then it is important to have a consistent method of determining depression severity. The marked disparity between standardized scales in the classification of depressed outpatients into severity groups indicates that there is a problem with the use of such instruments to classify depression severity. Caution is warranted in the use of these scales to guide treatment selection until the thresholds to define severity ranges have been empirically established.

Citing Articles

A systematic review and network meta-analysis of psychological, psychosocial, pharmacological, physical and combined treatments for adults with a new episode of depression.

Mavranezouli I, Megnin-Viggars O, Pedder H, Welton N, Dias S, Watkins E EClinicalMedicine. 2024; 75:102780.

PMID: 39246718 PMC: 11377144. DOI: 10.1016/j.eclinm.2024.102780.


Never Too Late: Safety and Efficacy of Deep TMS for Late-Life Depression.

Roth Y, Munasifi F, Harvey S, Grammer G, Hanlon C, Tendler A J Clin Med. 2024; 13(3).

PMID: 38337509 PMC: 10856385. DOI: 10.3390/jcm13030816.


A systematic review exploring characteristics of youth with severe and enduring mental health problems (SEMHP).

Bansema C, Vermeiren R, de Soet R, van Ewijk H, Nijland L, Nooteboom L Eur Child Adolesc Psychiatry. 2023; 33(5):1313-1325.

PMID: 37093338 PMC: 11098915. DOI: 10.1007/s00787-023-02216-6.


Content agreement of depressive symptomatology in children and adolescents: a review of eighteen self-report questionnaires.

Vilar A, Sanchez-Martinez N, Blasco M, Alvarez-Salazar S, Batlle Vila S, Forero C Eur Child Adolesc Psychiatry. 2022; 33(7):2019-2033.

PMID: 35962831 DOI: 10.1007/s00787-022-02056-w.


Outcomes reported in randomised controlled trials of major depressive disorder in older adults: protocol for a methodological review.

Rodrigues M, Sanger N, Dufort A, Sanger S, Panesar B, DElia A BMJ Open. 2021; 11(11):e054777.

PMID: 34725082 PMC: 8562520. DOI: 10.1136/bmjopen-2021-054777.